Enzymes in Industrial Applications: Global Markets

Report Code: BIO030F

Publish Date: Jan 2011

Publisher: BCC Publishing

Category: Cell Biology

Customize This Report

Explore Our Services

Already a member? Login to access this report free.

Report Highlights

The global market for industrial enzymes is estimated at $3.3 billion in 2010. This market is expected to reach $4.4 billion by 2015, a compound annual growth rate (CAGR) of 6% over the 5-year forecast period.

Report Scope

The scope of this study encompasses industrial enzymes, biotechnical, chemical, and biotechnology markets. BCC analyzes each market and its applications, regulatory environment, technology involved, market projections, and market share. Technological issues include the latest trends and developments.

Analyst Credentials

This study has been carried out by a team of professionals in the biotechnology industry. The project manager for this project is Shalini S. Dewan, who holds a master’s degree in pharmaceutical chemistry and has over 14 years of industry experience. Among the research topics she has covered are studies on compounds of potential pharmaceutical interest, from ibuprofen to 2-naphthyl acetic acid. Shalini was awarded a Gold Medal by the Prime Minister of India for her work and has worked with top companies in India and in the U.S.

Some of her other reports written for BCC are listed below:

  • Reagents of Chromatography; Spectroscopy, an Enduring Market
  • Advanced Drug Delivery Systems: New Developments, New Technologies
  • Orthopedic Drugs, Implants and Devices
  • Medical Imaging Reagents and Analysis Equipment
  • Pharmaceutical Regulatory Industry
  • The Dynamic Media, Sera and Reagent Market in Biotechnology
  • Contract Pharmaceutical Manufacturing, Research and Packaging
  • Chiral Technology: Global Markets
  • Autacoids and Related Drugs: Technologies and Global Markets
  • Contraceptives: Technologies and Global Markets
  • Liver Disease Treatments: The Global Market
  • Hormone Replacement Therapies and Other Hormone Therapies: Global Markets
  • Cardiovascular Medicine: Diagnostics, Drugs and Devices and Cancer Therapies: Technologies and Global Markets

The lead consultant for this project was Dr. Kapil A. Setia, who holds a doctoral degree in life sciences.

Need pricing for multiple titles, a complete report bundle, or something specially curated to fit your budget? EXPLORE OFFERS
Let us assist you! Our analysts are ready to tailor this report to your specific need. Talk to Our Analyst

Table of Contents

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter NamePagesMember Price
Full Report: Enzymes in Industrial Applications: Global Markets139Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: EXECUTIVE SUMMARY3Free
Chapter- 3: OVERVIEW8Free
Chapter- 4: CLASSIFICATION OF ENZYMES16Free
Chapter- 5: REGULATORY ASPECTS6Free
Chapter- 6: INDUSTRY STRUCTURE20Free
Chapter- 7: MARKET ANALYSIS52Free
Chapter- 8: PATENT ANALYSIS12Free
Chapter- 9: CURRENT SITUATION5Free
Chapter- 10: C. CRAMER & CO. GMBH12Free
Chapter- 11: APPENDIX: ABBREVIATIONS1Free

Related Reports

Track the Latest Global Tariff Developments

In today's fast-paced global economy, tariffs are no longer static—they are dynamic levers shaped by geopolitical realignments, supply chain vulnerabilities, inflationary pressures, and sustainability-driven trade reforms. As governments worldwide recalibrate their trade strategies, businesses are left to navigate a maze of shifting rules, rising costs, and regulatory uncertainty.

Our analysis empowers you with real-time updates and in-depth expert analysis on all facets of global tariff activity. From new trade agreements and sanctions to abrupt tariff hikes and retaliatory duties, we monitor developments across borders, sectors, and industries—so you don't have to.

Whether it's the ongoing U.S.–China trade dynamics, the evolving EU Carbon Border Adjustment Mechanism (CBAM), or the emerging policies in India, ASEAN, and Latin America, we provide full-spectrum coverage. We also track multilateral trade negotiations, World Trade Organization (WTO) rulings, and sector-specific duty structures—ensuring you are always ahead of global trade shifts.

With our analysis, you can stay informed, identify risks, and confidently respond to tariff changes—no matter where you operate.

Ready to see what tariff means for your business?

Consult with our experts or request your custom Tariff Impact Brife today

Stay Informed, Stay Competitive

In today's interconnected and unpredictable global economy, staying ahead of tariff shifts is not just important—it's essential. BCC Research provides decision-makers with trusted, research-driven insights that turn uncertainty into opportunity.

Our in-depth market analysis and trade intelligence help you decode how tariff changes impact your specific sector—manufacturing, healthcare, technology, agriculture, or energy. We break down complex data into actionable knowledge through comprehensive reports, expert commentaries, and sector-focused forecasts.

Our analysis includes:

  • Thorough breakdowns of current and proposed tariff policies and how they affect regional and global trade flows.
  • Sector-specific implications, helping you understand the strategic impact on sourcing, pricing, and competitiveness.
  • Forward-looking insights to support risk management, planning, and response strategies for evolving trade conditions.

With BCC Research, you gain more than just information—you gain clarity and confidence to make well-informed decisions in a volatile trade environment.

Don't let tariffs catch you off guard—let our insights guide your strategy.

This is an Excel-only version of the report.

Report Includes

    Total Number of Tables in this Report: 57

  • Summary Table: GLOBAL INDUSTRIAL ENZYMES MARKET, THROUGH 2015
  • Table 1: HISTORY OF ENZYMES
  • Table 2: PROTEIN ENGINEERED COMMERCIAL ENZYMES
  • Table 3: EXAMPLES OF GENETICALLY ENGINEERED ENZYMES
  • Table 4: ADVANTAGES AND DISADVANTAGES OF ENZYMES
  • Table 5: TYPES OF ENZYMES AND REACTIONS THEY CATALYZE
  • Table 6: DIFFERENCES BETWEEN INDUSTRIAL AND MEDICAL ENZYMES
  • Table 7: COMMONLY USED INDUSTRIAL ENZYMES
  • Table 8: COMMONLY USED ENZYMES IN DETERGENTS
  • Table 9: ENZYMES USED IN VARIOUS PROCESSES OF LEATHER MANUFACTURING
  • Table 10: ENZYMES USED IN THE BAKING INDUSTRY
Sample Report

Recent Reports

Global Cell Line and Membrane Market

Published - Jun 2025 | Publisher - BCC Publishing | Code - BIO178B

The global market for cell lines and membranes was valued at $5.7 billion in 2024 and is estimated to increase from $6.3 billion in 2025 to reach $11.4 billion by 2030, at a compound annual growth rate (CAGR) of 12.5% from 2025 through 2030.

Human Microbiome-based Drugs and Diagnostics: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO151B

The global market for human microbiome-based drugs and diagnostics is expected to grow from $393.4 million in 2025 to reach $1.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 25.6% from 2025 through 2030.

Global Microbiome Sequencing Market

Published - May 2025 | Publisher - BCC Publishing | Code - BIO183B

The global microbiome sequencing market is expected to grow from $1.5 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 19.3% during the forecast period of 2024 to 2029.

Proteomics: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO034G

The global market for proteomic technologies was valued at $27.6 billion in 2024. It is projected to grow from $31.0 billion in 2025 to $57.2 billion by the end of 2030, at a compound annual growth rate (CAGR) of 13.0% from 2025 to 2030.

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Top Trending Reports

Biologic Therapeutic Drugs: Technologies and Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - BIO079F

The global market for biologic therapeutic drugs is estimated to increase from $499.2 billion in 2024 to reach $794.5 billion by 2029, at a compound annual growth rate (CAGR) of 9.7% from 2024 through 2029.

Next-Generation Advanced Batteries: Global Markets

Published - May 2025 | Publisher - BCC Publishing | Code - FCB062B

The global market for next-generation advanced batteries is estimated to grow from $1.5 billion in 2024 to reach $5.3 billion by the end of 2029, at a compound annual growth rate (CAGR) of 28.5% from 2024 through 2029.

Global Pharmaceutical Drugs Industry: Competitive Landscape 2023

Published - May 2025 | Publisher - BCC Publishing | Code - PHM263B

This report discusses the global pharmaceutical drugs industry and its competitive landscape in terms of significant player market ranking and top pharmaceutical drugs. Company profiles of the top 50 pharmaceutical companies, innovative products and technologies, trends and market dynamics, competitive intelligence, and regional trends are well-researched and analyzed in this report.

Global Markets and Manufacturing Technologies for Protein Drugs

Published - Apr 2025 | Publisher - BCC Publishing | Code - BIO021G

The global protein drugs market is expected to grow from $441.7 billion in 2024 and is projected to reach $655.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 8.2% during the forecast period of 2024 to 2029.

Global Markets for Emerging Medical Device Technologies

Published - Mar 2025 | Publisher - BCC Publishing | Code - HLC191C

The global market for emerging medical devices is estimated to increase from $136.6 billion in 2024 to reach $223.9 billion by 2029, at a compound annual growth rate (CAGR) of 10.4% from 2024 through 2029.

Published - Jan-2008| Analyst - Yatin Thakore| Code - BIO030E

Report Highlights

This Report:

  • The global market for industrial enzymes increased from $2.2 billion in 2006 to an estimated $2.3 billion by the end of 2007. It should reach $2.7 billion by 2012, a compound annual growth rate (CAGR) of 4%.
  • The greatest growth rate is expected in the animal enzymes sector, with a CAGR of 6% between 2007 and 2012, helped in large part by the increased use of phytase enzymes to fight phosphate pollution.
  • New and emerging applications have helped drive demand for enzymes, and the industry is responding with a continuous stream of innovative products.
Published - Dec-2004| Analyst - Yatin Thakore| Code - BIO030D

Report Highlights

  • The global market for industrial enzymes is estimated at $2 billion in 2004 and is expected to rise at an average annual growth rate (AAGR) of 3.3% to $2.4 billion in 2009.
  • Volume growth of industrial enzymes is between a 4% and 5% AAGR, and is accompanied by decreasing prices.
  • Growth of the animal feed enzyme sector is somewhat higher, at nearly a 4% AAGR, helped by increased use of phytase enzyme to fight phosphate pollution.
  • Technical enzymes for detergent and pulp and paper manufacturing, among others, are the largest segment with a 52% share. Growth will parallel the overall market.

Published - Jun-2001| Analyst - George Innes| Code - BIO030C

Report Highlights

  • Total U.S. consumption of enzymes is estimated at $514 million in 2000.
  • Growing at an average annual rate (AAGR) of 4.1%, usage will reach $629.3 million by 2005.
  • Pulp and paper applications will show the most growth, at an AAGR of 6.5% through the period.
  • Detergent/cleaners are second, with 5% annually on average. Food and animal feed applications dominate the current market, accounting for just under half the total value.

Become A Member

BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.

Find Out More

Custom Consulting

BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.

Customize Now

Scorecard

The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.

Find Out More

Innovation Spotlight

Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.

Find Out More
Enzymes in Industrial Applications: Global Markets
Customize Report